By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ZIOPHARM Oncology, Inc. 

1180 Avenue of the Americas
19th Floor
New York  New York  10036  U.S.A.
Phone: 646-214-0700 Fax: 646-214-0711


Company News
ZIOPHARM Oncology (ZIOP) Announces Positive Updated Results Of Ad-RTS-Hil-12 + Veledimex In Recurrent Glioblastoma At The 2017 ASCO Annual Meeting 6/5/2017 12:58:24 PM
ZIOPHARM Oncology (ZIOP) Announces Results Of Ad-RTS-hIL-12 + Veledimex In Recurrent Glioblastoma To Be Presented At The 2017 ASCO Annual Meeting 5/18/2017 11:21:31 AM
ZIOPHARM Oncology (ZIOP) Announces Pricing Of $50 Million Follow-On Offering Of Common Stock 5/12/2017 8:21:21 AM
ZIOPHARM Oncology (ZIOP) Announces FDA Acceptance Of IND For CD33-Specific CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia 5/2/2017 8:29:05 AM
ZIOPHARM Oncology (ZIOP) Reports First Quarter 2017 Financial Results And Provides Update On Recent Activities 5/2/2017 8:27:20 AM
ZIOPHARM Oncology (ZIOP) To Host First-Quarter 2017 Financial Results And Corporate Update Conference Call On May 1, 2017 At 4:30 P.M. ET 4/24/2017 11:33:55 AM
ZIOPHARM Oncology (ZIOP) Release: Biopharma And Intrexon (XON) Announce Cooperative Research And Development Agreement With The NCI Utilizing Sleeping Beauty System To Generate T Cells Targeting Neoantigens 1/10/2017 10:42:37 AM
ZIOPHARM Oncology (ZIOP) Falls Some More After Experimental Gene Therapy is Tied to 'Higher Than Expected' Toxicity 10/10/2016 7:49:25 AM
4 Movers & Shakers in This Year’s Oncology Market 6/15/2016 6:48:59 AM
Journalist Criticizes ZIOPHARM Oncology (ZIOP.OB) as Its Own ‘Biotech Bubble’ Held Aloft by Ties to R.J. Kirk's Intrexon (XON) 5/20/2016 5:59:59 AM